MET and neoplasm: In the current analysis, we focused on the role of selected molecular candidates related to c-MET signaling in tumor tissue to predict histopathologic and oncologic outcomes and the effect of their inhibition in unique treatment-naïve as well as resistant PeCa cell lines generated by our research group, thus mimicking clinical scenarios of the second- and third-line systemic treatment.